Hyperaldosteronism

Last updated: January 26, 2026

Hyperaldosteronism

Dr. Andrews

Dr. Andrews

Cell cycle
Oncogenes and tumor suppressor genes
Non-Hodgkin lymphoma
Hodgkin lymphoma
DiGeorge syndrome
Hydronephrosis
Acute pyelonephritis
Chronic pyelonephritis
Vesicoureteral reflux
Bladder exstrophy
BK virus (Hemorrhagic cystitis)
Non-urothelial bladder cancers
Development of the umbilical cord
Development of the fetal membranes
Dizziness and vertigo: Clinical
Reactive arthritis
Klinefelter syndrome
Testicular tumors: Pathology review
DNA alkylating medications
Androgens and antiandrogens
PDE5 inhibitors
Adrenergic antagonists: Alpha blockers
Estrogens and antiestrogens
Progestins and antiprogestins
Aromatase inhibitors
Uterine stimulants and relaxants
Anatomy of the pelvic cavity
Pelvic inflammatory disease
Vulvar cancer: Clinical
Vaginal and vulvar disorders: Pathology review
Chlamydia trachomatis
Papulosquamous skin disorders: Clinical
Transitional cell carcinoma
Human papillomavirus
Paget disease of the breast
Vascular tumors
Development of the digestive system and body cavities
Nephroblastoma (Wilms tumor)
Development of the renal system
Antimetabolites for cancer treatment
Hypothyroidism: Pathology review
Hashimoto thyroiditis
Hyperthyroidism: Pathology review
Thyroid cancer
Thyroid nodules and thyroid cancer: Pathology review
Riedel thyroiditis
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal masses and tumors: Clinical
Sheehan syndrome
Cervical cancer
Ovarian cyst
Pheochromocytoma
Multiple endocrine neoplasia: Pathology review
Carcinoid syndrome
Vaginal cancer: Clinical
Acromegaly
Multiple endocrine neoplasia
Parathyroid hormone
Cystic fibrosis
Preeclampsia & eclampsia
Necrotizing enterocolitis
Neonatal respiratory distress syndrome
Galactosemia
Phenylketonuria (NORD)
WAGR syndrome
Focal segmental glomerulosclerosis (NORD)
Nephrotic syndromes: Pathology review
Membranoproliferative glomerulonephritis
Nephritic syndromes: Pathology review
IgA nephropathy (NORD)
Diabetic nephropathy
Membranous nephropathy
Minimal change disease
Ribonucleotide reductase inhibitors
Alport syndrome
Rapidly progressive glomerulonephritis
Goodpasture syndrome
Neurogenic bladder
Polycystic ovary syndrome
Endometrial hyperplasia
Renal system anatomy and physiology
Medullary cystic kidney disease
Krukenberg tumor
Polycystic kidney disease
Multicystic dysplastic kidney
Medullary sponge kidney
Horseshoe kidney
The role of the kidney in acid-base balance
Pancreatic cancer
Pancreatic neuroendocrine neoplasms
Acute pancreatitis
Chronic pancreatitis
Microtubule inhibitors
Bordetella pertussis (Whooping cough)
Topoisomerase inhibitors
Breast cancer
Prostate disorders and cancer: Pathology review
Antidiuretic hormone
Estrogen and progesterone
Li-Fraumeni syndrome
Renal agenesis
Gene regulation
Familial adenomatous polyposis
Mendelian genetics and punnett squares
Uterine fibroid
Respiratory acidosis
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
Peutz-Jeghers syndrome
Anatomy of the perineum

Transcript

Watch video only

With hyperaldosteronism, "hyper" means too much, and "aldosteronism" refers to the hormone aldosterone, which is made by the adrenal glands. So, hyperaldosteronism is a condition where the adrenal glands produce too much aldosterone.

Now, each of the two adrenal glands sits on top of a kidney and has two main parts.

The inner part, the medulla, produces the hormones epinephrine and norepinephrine.

On the flip side, the outer part, the cortex, has three layers. The innermost layer, the zona reticularis, produces androgens, such as dehydroepiandrosterone, which is a precursor of testosterone. The middle layer, the zona fasciculata, produces glucocorticoids, like cortisol. With glucocorticoids, “gluco-” refers to glucose, because they help increase blood glucose levels. The outermost layer, the zona glomerulosa, produces mineralocorticoids, such as aldosterone. With mineralocorticoids, “mineralo-” refers to minerals, because these hormones help regulate sodium and potassium levels. Now, the zona glomerulosa is controlled by the renin-angiotensin-aldosterone system.

When blood pressure or sodium levels drop, the juxtaglomerular cells in the kidneys release renin into the bloodstream. In the bloodstream, renin cleaves angiotensinogen into angiotensin I, which is later converted by angiotensin-converting enzyme or ACE, into angiotensin II.

Angiotensin II raises blood pressure through two mechanisms.

First, it triggers vasoconstriction of small arterioles, subsequently increasing peripheral vascular resistance. Second, angiotensin II stimulates the zona glomerulosa to release aldosterone.

Once in the bloodstream, aldosterone travels to the kidneys, more specifically, to the distal tubules and collecting ducts of the nephron.

Here, aldosterone squeezes into principal cells and stimulates mineralocorticoid receptors. When aldosterone activates mineralocorticoid receptors, the sodium-potassium pumps kick into high gear.
They begin to pump more sodium ions from the cell into the bloodstream.

This intracellular drop in sodium pulls more sodium from the tubule into the cell, following its concentration gradient. As sodium moves, water follows, so more water leaves the tubule and enters the blood vessels, eventually increasing blood volume and raising blood pressure.

At the same time, pumps pull potassium from the blood into the cells.

From here, potassium flows down its concentration gradient into the tubule to get excreted in the urine. That’s why another key trigger for the zona glomerulosa to release aldosterone is a high potassium level in the blood. Aldosterone helps the body remove extra potassium while holding on to sodium and water.

Now, based on the underlying pathology, hyperaldosteronism can be further subdivided into primary- and secondary types.

Primary hyperaldosteronism means that the adrenal glands are responsible for the excess production of aldosterone. The most common cause of primary hyperaldosteronism is bilateral idiopathic hyperaldosteronism. “Bilateral” means it affects both adrenal glands, and “idiopathic” means we’re not sure what’s causing it. But if we slice through the adrenal glands, we can recognize this condition by focal or widespread hyperplasia of cells that resemble those in the zona glomerulosa, which produce aldosterone.

Next, there are adrenocortical neoplasms.

Sources

  1. "Robbins & Kumar Basic Pathology. Available from: ClinicalKey Student, (11th Edition). Page 668-669 " Elsevier Limited (UK) (2022)
  2. "Robbins & Cotran Pathologic Basis of Disease. Available from: ClinicalKey Student, (10th Edition). Page 1118-1119 " Elsevier Health Sciences (US) (2020)
  3. "USMLE Step 1 Secrets in Color. Available from: ClinicalKey Student, (5th Edition). Page 174 " Elsevier Limited (UK) (2022)
  4. "Conn's Current Therapy 2024. Available from: ClinicalKey Student, Page 343-345 " Elsevier Limited (UK) (2023)
  5. "Textbook of Medical Physiology. Available from: ClinicalKey Student, (14th Edition). Page 955-962 " Elsevier Health Sciences (US) (2020)